FMP

FMP

Enter

BBLG - Bone Biologics Corpo...

Financial Summary of Bone Biologics Corporation(BBLG), Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion

photo-url-https://financialmodelingprep.com/image-stock/BBLG.png

Bone Biologics Corporation

BBLG

NASDAQ

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. The company was founded in 2004 and is headquartered in Burlington, Massachusetts.

1.5 USD

-0.01 (-0.667%)

About

ceo

Mr. Jeffrey Frelick

sector

Healthcare

industry

Medical - Devices

website

https://www.bonebiologics.com

exchange

NASDAQ

Description

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. It is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has...

CIK

0001419554

ISIN

US0980705018

CUSIP

098070303

Address

2 Burlington Woods Drive

Phone

781 552 4452

Country

US

Employee

2

IPO Date

Oct 13, 2021

Summary

CIK

0001419554

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

098070303

ISIN

US0980705018

Country

US

Price

1.5

Beta

0.63

Volume Avg.

106.67k

Market Cap

1.65M

Shares

-

52-Week

1.38-55.12

DCF

19.8

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

0.08

P/B

-

Website

https://www.bonebiologics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest BBLG News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep